Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze RAPT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate RAPT investment potential.

What is RAPT stock price today?

Get real-time RAPT stock price, historical data, and price charts on Financhill. Track RAPT performance with our advanced analysis tools.

Is RAPT a good investment?

Evaluate RAPT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy RAPT stock?

To buy RAPT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of RAPT?

View detailed market capitalization data and company valuation metrics for RAPT on our comprehensive analysis page.

What is the P/E ratio of RAPT?

Use our fundamental analysis tools to view RAPT P/E ratio and compare valuation metrics with industry peers.

What are RAPT earnings?

View RAPT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Rapt Therapeutics, Inc. Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

RAPT
Rapt Therapeutics, Inc.

Last Price:

$34.42

Seasonality Move:

11.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Rapt Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 0.1% based on the past 6 years of stock performance.
Rapt Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Rapt Therapeutics, Inc. Stock Undervalued?

The current Rapt Therapeutics, Inc. [RAPT] share price is $34.47. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Rapt Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 0.1% based on the past 6 years of stock performance.

Rapt Therapeutics, Inc. Stock Rating

Sell

Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. overpriced?

Rapt Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Rapt Therapeutics, Inc. Stock Price History

Is RAPT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

rapt.com

52-Week Data

52-Week High:

42.39

52-Week Low:

5.67

Prediction Charts

Market Cap:

570.1M

Price in USD:

34.47

Volume:

441.1K

Beta:

0.32

Technical Analysis

SMA50:

29.26

SMA100:

21.13

SMA200:

14.70

52-Wk Change:

308.41%

Stock Predictions

Is Rapt Therapeutics, Inc. stock public?

Yes, Rapt Therapeutics, Inc. is a publicly traded company.
What is the Rapt Therapeutics, Inc. stock quote today?

The Rapt Therapeutics, Inc. stock price is 34.47 USD today.
How to buy Rapt Therapeutics, Inc. stock online?

You can buy Rapt Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	26.97	28.85	29.28	26.78
Nov-17	28.99	28.65	29.53	28.50
Nov-18	28.07	28.28	28.86	27.95
Nov-19	27.97	28.32	28.72	27.60
Nov-20	29.29	27.28	29.29	27.00
Nov-21	27.61	27.08	27.79	26.50
Nov-24	27.67	29.12	29.66	27.67
Nov-25	29.00	29.97	30.28	28.75
Nov-26	30.15	33.26	34.46	29.76
Nov-28	33.26	33.80	35.10	32.17
Dec-1	33.56	31.51	33.56	31.44
Dec-2	31.52	32.33	32.40	30.00
Dec-3	32.25	32.09	32.50	31.24
Dec-4	32.08	34.47	34.73	31.72

Rapt Therapeutics, Inc. Earnings

Rapt Therapeutics, Inc. Earnings Report: Per Share Rapt Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Rapt Therapeutics, Inc. Forecast Revenue Growth

Rapt Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Rapt Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.70 per share, and a decrease next year of $0.91 per share.

* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.